Lanean...
LIPOSOMAL SIRNA NANOCARRIERS FOR CANCER THERAPY
Small interfering RNAs (siRNA) have recently emerged as a new class of therapeutics with a great potential to revolutionize the treatment of cancer and other diseases. A specifically designed siRNA binds and induces post-transcriptional silencing of target genes (mRNA). Clinical applications of siRN...
Gorde:
| Argitaratua izan da: | Adv Drug Deliv Rev |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4527165/ https://ncbi.nlm.nih.gov/pubmed/24384374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2013.12.008 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|